Zacks Small Cap Research – MTVA: Positive Phase 1 MAD Data for DA-1726; Excellent Tolerability Profile and Mean Day 26 Weight Loss of 4.3%… – Go Health Pro

Zacks Small Cap Research – MTVA: Positive Phase 1 MAD Data for DA-1726; Excellent Tolerability Profile and Mean Day 26 Weight Loss of 4.3%… – Go Health Pro

By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity. The results showed that the cohort receiving 32 mg of … Read more

ISPs say their “excellent customer service” is why users don’t switch providers – Go Health Pro

ISPs say their “excellent customer service” is why users don’t switch providers – Go Health Pro

If the FCC leadership wasn’t changing hands, the Notice of Inquiry could be the first step toward a rulemaking. “We cannot ignore these complaints, especially not when we know that it is possible to do better… We want to help improve the customer experience, understand what tools we have to do so, and what gaps … Read more